The Hidden Costs of Vertical Integration in Medicare Part D
A May 2026 audit from the Department of Health and Human Services (HHS) Office of Inspector General reveals that vertical integration within the prescription drug supply chain delivers a paradoxical outcome for Medicare Part D beneficiaries: lower monthly premiums coupled with significantly higher out-of-pocket expenses. The report highlights how large corporations controlling insurance providers, pharmacy…
